{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/16892794"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "On the basis of the determination of the marker provasopressin (proAVP) or fragments and partial peptides thereof, particularly copeptin and neurophysin II, great sensitivity and specificity for infections or chronic diseases of the airways and lungs are achieved, and the diagnosis or risk stratification can take place using the amount that is present in at least one patient sample." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "freshpatents.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/57341839"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/16892794" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/342945990"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/16892794" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/141458054"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/16892794" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/30932719"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/16892794"] } } }
